Luo_2024_Future.Med.Chem_16_983

Reference

Title : Design, synthesis and biological evaluation of 1-aryldonepezil analogues as anti-Alzheimer's disease agents - Luo_2024_Future.Med.Chem_16_983
Author(s) : Luo J , Xu JJ , Ren HJ , Xu JB , Gao F , Fang DM , Wan LX
Ref : Future Med Chem , 16 :983 , 2024
Abstract :

Aim: To design and synthesize a novel series of 1-aryldonepezil analogues. Materials & methods: The 1-aryldonepezil analogues were synthesized through palladium/PCy(3)-catalyzed Suzuki reaction and were evaluated for cholinesterase inhibitory activities and neuroprotective effects. In silico docking of the most effective compound was conducted. Results: The 4-tert-butylphenyl analogue exhibited good inhibitory potency against acetylcholinesterase and butyrylcholinesterase and had a favorable neuroprotective effect on H(2)O(2)-induced SH-SY5Y cell injury. Conclusion: The 4-tert-butylphenyl derivative is a promising lead compound for anti-Alzheimer's disease drug development.

PubMedSearch : Luo_2024_Future.Med.Chem_16_983
PubMedID: 38910574

Related information

Citations formats

Luo J, Xu JJ, Ren HJ, Xu JB, Gao F, Fang DM, Wan LX (2024)
Design, synthesis and biological evaluation of 1-aryldonepezil analogues as anti-Alzheimer's disease agents
Future Med Chem 16 :983

Luo J, Xu JJ, Ren HJ, Xu JB, Gao F, Fang DM, Wan LX (2024)
Future Med Chem 16 :983